Can BioNTech Take China Early-Stage Biotech Innovation Global?

BioNTech is betting on China's innovative capabilities by inking multiple deals with local startups to expand its pipeline beyond mRNA vaccines.

Mainz, Rheinland-Pfalz, Germany-9. September 2020 Biontech building in Mainz with the sun shining and waving flags
BioNTech has signed on multiple Chinese biotechs in the past few months to expand its pipeline • Source: Florian Imbusch / Shutterstock.com

Zhuhai, Guangdong-based Biotheus Inc. is one of four Chinese biotechs now partnering with German mRNA specialist BioNTech SE to bring its innovative drugs to the global market.

More from China

More from Focus On Asia